Literature DB >> 9861568

Necrotizing fasciitis caused by Vibrio vulnificus: first published infection acquired in Turkey is the second time a strain is isolated in Germany.

R Horré1, S Becker, G Marklein, T Shimada, R Stephan, K Steuer, E Bierhoff, K P Schaal.   

Abstract

Vibrio vulnificus, a marine vibrio, has recently been recognized as a potential human pathogen. It causes human infections with mortality rates up to 60%. Until 1991, most human isolations were reported from the USA, Japan and Taiwan. The second strain isolated in Germany is documented and a significant case of V. vulnificus infection acquired in Turkey is published for the first time.

Entities:  

Mesh:

Year:  1998        PMID: 9861568     DOI: 10.1007/bf02770844

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Comparison of a commercial biochemical kit and an oligonucleotide probe for identification of environmental isolates of Vibrio vulnificus.

Authors:  A Dalsgaard; I Dalsgaard; L Høi; J L Larsen
Journal:  Lett Appl Microbiol       Date:  1996-02       Impact factor: 2.858

2.  Vibrio vulnificus: did Hippocrates describe a fatal case?

Authors:  B A Baethge; B C West
Journal:  Rev Infect Dis       Date:  1988 May-Jun

3.  Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community.

Authors:  C W Hoge; D Watsky; R N Peeler; J P Libonati; E Israel; J G Morris
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

4.  Seasonal variations in the occurrence of Vibrio vulnificus along the Dutch coast.

Authors:  J Veenstra; P J Rietra; J M Coster; E Slaats; S Dirks-Go
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

5.  Significant role of an exocellular protease in utilization of heme by Vibrio vulnificus.

Authors:  Y Nishina; S Miyoshi; A Nagase; S Shinoda
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Resuscitation of Vibrio vulnificus from the viable but nonculturable state.

Authors:  L Nilsson; J D Oliver; S Kjelleberg
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

7.  The first fatal case of Vibrio vulnificus infection in Denmark.

Authors:  T Bock; N Christensen; N H Eriksen; S Winter; H Rygaard; F Jørgensen
Journal:  APMIS       Date:  1994-11       Impact factor: 3.205

8.  Evidence that water transmits Vibrio vulnificus biotype 2 infections to eels.

Authors:  C Amaro; E G Biosca; B Fouz; E Alcaide; C Esteve
Journal:  Appl Environ Microbiol       Date:  1995-03       Impact factor: 4.792

9.  First documented case of bacteremia with Vibrio vulnificus in Sweden.

Authors:  A Melhus; T Holmdahl; I Tjernberg
Journal:  Scand J Infect Dis       Date:  1995

10.  Clinical and microbiological features of necrotizing fasciitis.

Authors:  I Brook; E H Frazier
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  4 in total

1.  Sepsis with bullous necrotizing skin lesions due to vibrio vulnificus acquired through recreational activities in the Baltic Sea.

Authors:  K Kuhnt-Lenz; S Krengel; S Fetscher; A Heer-Sonderhoff; W Solbach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-04       Impact factor: 3.267

2.  Comparative genomic analysis of clinical and environmental Vibrio vulnificus isolates revealed biotype 3 evolutionary relationships.

Authors:  Yael Koton; Michal Gordon; Vered Chalifa-Caspi; Naiel Bisharat
Journal:  Front Microbiol       Date:  2015-01-15       Impact factor: 5.640

3.  Synchronous multifocal necrotizing fasciitis prognostic factors: a retrospective case series study in a single center.

Authors:  Ching-Yu Lee; Yen-Yao Li; Tsan-Wen Huang; Tsung-Yu Huang; Wei-Hsiu Hsu; Yao-Hung Tsai; Jou-Chen Huang; Kuo-Chin Huang
Journal:  Infection       Date:  2016-10-24       Impact factor: 3.553

4.  "The Baltic Sea Germ": A Case Report of Necrotizing Fasciitis following Vibrio vulnificus Infection.

Authors:  Heinz-Lothar Meyer; Christina Polan; Manuel Burggraf; Lars Podleska; Paula Beck; Hans-Ulrich Steinau; Marcel Dudda; Farhad Farzaliyev
Journal:  Case Rep Orthop       Date:  2022-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.